280
Participants
Start Date
February 3, 2022
Primary Completion Date
May 27, 2027
Study Completion Date
May 27, 2027
pembrolizumab
Intravenous (IV) infusion
carboplatin
IV infusion
paclitaxel
IV infusion
docetaxel
IV infusion
cisplatin
IV infusion
Taichung Veterans General Hospital ( Site 2602), Taichung
NATIONAL CHENG-KUNG UNI. HOSP. ( Site 2604), Tainan City
Institut Jules Bordet-Medicine Oncology ( Site 0321), Brussels
Auckland City Hospital-Cancer & Blood Research ( Site 1801), Auckland
Országos Onkológiai Intézet-Ngyógyászat ( Site 1201), Budapest
Northern Cancer Institute ( Site 0206), St Leonards
Rigshospitalet ( Site 0903), Copenhagen
Westmead Hospital-Department of Gynaecological Oncology ( Site 0201), Westmead
Herlev and Gentofte Hospital ( Site 0902), Copenhagen
Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0207), Melbourne
Epworth Freemasons ( Site 0203), Melbourne
Monash Health ( Site 0202), Clayton
Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman ( Site 0320), Liège
Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si, Brisbane
Grand Hôpital de Charleroi-Oncology & Hematology ( Site 0323), Charleroi
St. John of God Subiaco Hospital-Oncology Clinical Trials Unit ( Site 0204), Subiaco
Aalborg Universitetshospital, Syd ( Site 0905), Aalborg
National Taiwan University Hospital ( Site 2603), Taipei
The Blavatnik Family- Chelsea Medical Center at Mount Sinai ( Site 0023), New York
Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0016), New York
Icahn School of Medicine at Mount Sinai ( Site 0052), New York
Fakultni nemocnice Kralovske Vinohrady-Gynekologicko-porodnická klinika ( Site 0408), Prague
Memorial Sloan Kettering Cancer Center ( Site 0009), New York
Ospedale Mauriziano-SCDU ONCOLOGIA MEDICA ( Site 1514), Turin
Mackay Memorial Hospital ( Site 2601), Taipei
Taipei Veterans General Hospital ( Site 2605), Taipei
Vseobecna fakultni nemocnice v Praze-Gynekologicko-porodnicka klinika 1.LF a VFN ( Site 0405), Prague
Charité Campus Virchow-Klinikum ( Site 1103), Berlin
CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 2405), A Coruña
University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0034), Pittsburgh
AHN West Penn Hospital ( Site 0011), Pittsburgh
Asplundh Cancer Pavilion ( Site 0014), Willow Grove
Sidney Kimmel Cancer Center - Jefferson Health ( Site 0053), Philadelphia
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Chirurgia Ginecologica ( Site 150, Milan
Istituto Europeo di Oncologia IRCCS-Divisione di Ginecologia Oncologica ( Site 1506), Milan
Maryland Oncology Hematology, P.A.-USOR Maryland Oncology Hematology, P.A. ( Site 8002), Rockville
Skånes Universitetssjukhus Lund-Department of Hematology ( Site 2504), Lund
VCU Health Adult Outpatient Pavillion ( Site 0022), Richmond
Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 2402), Madrid
FirstHealth Clinical Trials ( Site 0050), Pinehurst
Southeastern Regional Medical Center ( Site 0046), Newnan
Northside Hospital ( Site 0017), Atlanta
COMPLEJO HOSPITALARIO DE NAVARRA ( Site 2407), Pamplona
Mount Sinai Cancer Center ( Site 0018), Miami Beach
Tampereen yliopistollinen sairaala-Gynecology and Obstetrics ( Site 1001), Tampere
Istanbul University Capa Campus-department of obstetrics and gynaecology ( Site 2705), Istanbul
Istanbul Universitesi Cerrahpasa ( Site 2702), Fatih
Sarasota Memorial Hospital ( Site 0005), Sarasota
T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma, Istanbul
AULSS8 Berica-Ospedale S.Bortolo-ONCOLOGIA CLINICA ( Site 1510), Vicenza
St. Dominic's Hospital ( Site 0024), Jackson
IRCCS - AOU di Bologna-SSD Oncologia medica Addarii ( Site 1503), Bologna
Baptist Health Lexington ( Site 0042), Lexington
HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO ( Site 2401), Seville
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus
University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0039), Cincinnati
Fundación Instituto Valenciano de Oncología-Oncologico ( Site 2404), Valencia
St. Vincent Hospital and Health Care Center, Inc ( Site 0006), Indianapolis
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Oncologia Medica ( Site 1513), Meldola
Karmanos Cancer Institute ( Site 0029), Detroit
Azienda Ospedaliera Universitaria Careggi-SOD ONCOLOGIA MEDICA ( Site 1509), Florence
Universitätsklinikum Bonn-Gynaecological oncology ( Site 1105), Bonn
Sanford Cancer Center-Gynecologic Oncology ( Site 0002), Sioux Falls
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0055), Fargo
Sanford Medical Center ( Site 0054), Bismarck
Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003), Zion
Fakultní nemocnice Brno Bohunice-Gynekologicko-porodnicka klinika ( Site 0404), Brno
Kuopion Yliopistollinen Sairaala ( Site 1002), Kuopio
Texas Oncology - Dallas-USOR Texas Oncology - Dallas (Sammons) ( Site 8005), Dallas
Texas Oncology - Tyler-USOR Texas Oncology - Northeast Texas ( Site 8004), Tyler
Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003), Austin
Istituto Nazionale Tumori IRCCS Fondazione Pascale-S.C. Oncologia Sperimentale Uro-Genitale ( Site 1, Napoli
HonorHealth-USOR HonorHealth ( Site 8000), Phoenix
Universitaetsklinikum Ulm ( Site 1106), Ulm
Kaiser Permanente Riverside Medical Center ( Site 0045), Riverside
Providence Portland Medical Center ( Site 0031), Portland
Beijing Obstetric and Gynecology Hospital ( Site 0740), Beijing
Peking University First Hospital ( Site 0723), Beijing
Beijing Cancer hospital ( Site 0715), Beijing
The First Hospital of Jilin University ( Site 0705), Changchun
Moscow City Oncology Hospital #62 ( Site 2204), Krasnogorsk
Yaroslavl Regional Cancer Hospital-Oncology ( Site 2202), Yaroslavl
Harbin Medical University Cancer Hospital ( Site 0711), Harbin
Obstetrics & Gynecology Hospital of Fudan University ( Site 0702), Shanghai
Shanghai First Maternity and Infant Hospital-Gynecology department ( Site 0717), Shanghai
Jiangsu Province Hospital-Oncology Department ( Site 0707), Nanjing
Anhui Provincial Hospital-Obstetrics and Gynecology ( Site 0730), Hefei
Binzhou Medical University Hospital-Oncology department ( Site 0735), Binzhou
Tianjin Medical University Cancer Institute and Hospital ( Site 0706), Tianjin
The Affiliated Women's Hospital of Zhejiang University-Obstetrics and Gynecology ( Site 0726), Hangzhou
Zhejiang Cancer Hospital-Oncology ( Site 0700), Hangzhou
The First Affiliated Hospital of Wenzhou Medical University-Gynecology ( Site 0725), Wenzhou
The First Affiliated Hospital of Nanchang University ( Site 0729), Nanchang
Fujian Provincial Cancer Hospital ( Site 0720), Fuzhou
Southwest Hospital of Third Military Medical University ( Site 0719), Chongqing
2nd Affiliated Hospital Chongqing Medical Universi ( Site 0745), Chongqing
Fuling Central Hospital ( Site 0733), Fulingqu
Xiangya Hospital Central South University-Gynecology ( Site 0708), Changsha
Hunan Cancer Hospital ( Site 0709), Changsha
Wuhan Union Hospital-Medical Oncology ( Site 0716), Wuhan
Henan Cancer Hospital ( Site 0713), Zhengzhou
SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 0710), Guangzhou
Cancer Hospital of Shantou University Medical College ( Site 0732), Shantou
Affiliated Hospital of Guangdong Medical College ( Site 0731), Zhanjiang
Guangxi Medical University Affiliated Tumor Hospital-Gynecological oncology ( Site 0704), Nanning
Hainan General Hospital ( Site 0703), Haikou
West China Second University Hospital Sichuan University ( Site 0701), Chengdu
Yunnan Province Cancer Hospital-Gynecology Department ( Site 0721), Kunming
Shaanxi Provincial Cancer Hospital ( Site 0714), Xi'an
Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402), Haifa
Sheba Medical Center ( Site 1401), Ramat Gan
Edith Wolfson Medical Center-Obstetrics & Gynecology ( Site 1405), Holon
FALP-UIDO ( Site 0602), Santiago
Pontificia Universidad Catolica de Chile-Centro del Cáncer ( Site 0604), Santiago
Soroka Medical Center ( Site 1403), Beersheba
Bradfordhill-Clinical Area ( Site 0603), Santiago
Shaare Zedek Medical Center ( Site 1404), Jerusalem
Moores Cancer Center ( Site 0037), La Jolla
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0013), New Haven
University of Massachusetts Medical School-Division of Gynecologic Oncology ( Site 0008), Worcester
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0026), Hackensack
Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 3005), Natal
ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 3001), São Paulo
A. C. Camargo Cancer Center-CAPEC ( Site 3003), São Paulo
Cross Cancer Institute ( Site 0513), Edmonton
BC Cancer Kelowna ( Site 0517), Kelowna
BC Cancer Vancouver-Clinical Trials Unit ( Site 0518), Vancouver
Sunnybrook Health Sciences - Odette Cancer Centre ( Site 0509), Toronto
Princess Margaret Cancer Centre ( Site 0510), Toronto
Centre Hospitalier de l'Université de Montréal ( Site 0519), Montreal
Jewish General Hospital ( Site 0504), Montreal
McGill University Health Centre ( Site 0505), Montreal
Saskatoon Cancer Center-Clinical Research Department ( Site 0520), Saskatoon
Fakultni nemocnice Ostrava-Gynekologicko-porodnicka klinika ( Site 0403), Ostrava
Nemocnice AGEL Novy Jicin a.s.-Oddeleni radioterapie a onkologie ( Site 0406), Nový Jiín
Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0402), Olomouc
Fakultni nemocnice Bulovka-Gynekologicko-porodnicka klinika ( Site 0401), Prague
Nemocnice Tomase Bati ve Zline-Onkologické oddělení ( Site 0407), Zlín
Roskilde Sygehus-Oncology department ( Site 0904), Roskilde
Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus) ( Site 1003), Helsinki
Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Frauenheilkunde und Gebur, Dresden
Bon Secours Cork Hospital ( Site 1305), Cork
St. James's Hospital-Cancer clinical trials office ( Site 1301), Dublin
Fondazione Policlinico Universitario Agostino Gemelli-Ginecologia Oncologica ( Site 1502), Rome
Istituto Nazionale Tumori Regina Elena-Oncologia Medica 1 ( Site 1504), Rome
National Cancer Center Hospital East ( Site 1604), Kashiwa
National Hospital Organization Shikoku Cancer Center ( Site 1611), Matsuyama
Ehime University Hospital ( Site 1614), Tōon
Kurume University Hospital ( Site 1612), Kurume
Gunma Prefectural Cancer Center-Gynecology ( Site 1603), Ōta
Hokkaido University Hospital ( Site 1601), Sapporo
Tsukuba University Hospital ( Site 1618), Tsukuba
Iwate Medical University Hospital ( Site 1602), Shiwa-gun Yahaba-cho
Niigata University Medical & Dental Hospital ( Site 1613), Chuo-ku, Niigata
Saitama Medical University International Medical Center ( Site 1605), Hidaka-shi
Shizuoka Cancer Center ( Site 1609), Nagaizumi-cho,Sunto-gun
National Cancer Center Hospital ( Site 1607), Chuo-ku
Japanese Foundation for Cancer Research ( Site 1616), Koto
The Jikei University Hospital ( Site 1615), Minato-ku
Keio university hospital ( Site 1606), Shinjyuku-ku
National Hospital Organization Kyushu Cancer Center ( Site 1608), Fukuoka
Osaka International Cancer Institute ( Site 1617), Osaka
Radboudumc-Medical Oncology ( Site 1703), Nijmegen
Maastricht UMC+ ( Site 1709), Maastricht
Catharina Ziekenhuis-Oncology ( Site 1704), Eindhoven
Amsterdam UMC, locatie AMC ( Site 1706), Amsterdam
Leids Universitair Medisch Centrum-Medical Oncology ( Site 1702), Leiden
Erasmus Medisch Centrum-Medical Oncology ( Site 1701), Rotterdam
University Medical Center Groningen ( Site 1707), Groningen
Universitair Medisch Centrum Utrecht-Medical Oncology ( Site 1705), Utrecht
Oslo universitetssykehus, Radiumhospitalet ( Site 1901), Oslo
Szpital Kliniczny im. Heliodora Święcickiego Uniwersytetu Me-Oddzial Ginekologii Onkologicznej ( Sit, Poznan
Centrum Onkologii Ziemi Lubelskiej ( Site 2006), Lublin
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2007), Siedlce
Szpital Kliniczny im. Księżnej Anny Mazowieckiej ( Site 2009), Warsaw
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit, Warsaw
Bialostockie Centrum Onkologii-Oddzial Onkologii Ginekologicznej ( Site 2003), Bialystok
Narodowy Instytut Onkologii - Oddzial w Gliwicach-III Klinika Radioterapii i Chemioterapii ( Site 20, Gliwice
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej ( Site 2010), Kielce
Seoul National University Hospital ( Site 2302), Seoul
Severance Hospital, Yonsei University Health System-Gynecologic cancer center ( Site 2301), Seoul
Asan Medical Center-Division of Gynecologic Oncology, Dept. of Obstetrics & Gynecology ( Site 2303), Seoul
Gangnam Severance Hospital ( Site 2304), Seoul
Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2406), Hospitalet
Hospital Universitari Vall d'Hebron ( Site 2403), Barcelona
Karolinska Universitetssjukhuset Solna ( Site 2502), Solna
Norrlands universitetssjukhus-Cancercentrum ( Site 2503), Umeå
Hacettepe Universite Hastaneleri-oncology hospital ( Site 2704), Ankara
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 2706), Ankara
Akdeniz Universitesi Hastanesi ( Site 2701), Antalya
St Bartholomew's Hospital ( Site 2804), London
The Christie ( Site 2807), Manchester
The Beatson West of Scotland Cancer Centre ( Site 2805), Glasgow
ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 2806), London
Hammersmith Hospital-Medical Oncology ( Site 2808), London
European Network of Gynaecological Oncological Trial Groups (ENGOT)
OTHER
GOG Foundation
NETWORK
Merck Sharp & Dohme LLC
INDUSTRY